Search

everythinglearnresearchcommunity

for

Search:↓

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

FA2H is essential for normal fur and sebum production in mice.

GLI2 increases follistatin production in human skin cells.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

New compounds may soon be tested to treat excessive hair growth in women.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Light microscopy is useful for diagnosing different hair disorders.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.